Cimmino et al reported that restoration of TET2 reversed aberrant hematopoietic stem and progenitor cell self-renewal in vitro and in vivo, and suppressed human leukemic colony formation and leukemia progression of primary human leukemia patient-derived xenografts [9]. The gene discussed is TET2; the disease is leukemia.